Love of sports bested disease for Libertyville man
Daily Herald Fri, 14 Dec 2007 10:30 PM PST
A diagnosis of multiple sclerosis never dimmed Irwin Czosek's love of sports or life. Czosek, 74, of Libertyville, died Wednesday at the Westmoreland Nursing Center in Lake Forest.

BioMS Medical's Pivotal International Multiple Sclerosis Trial Receives Positive Review From Data Safety Monitoring ...
Medical News Today Sat, 15 Dec 2007 1:09 AM PST
BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), announced that following the meeting of the independent Data Safety Monitoring Board (DSMB), the Company has received a recommendation to continue MAESTRO-01, its pivotal phase II/III clinical trial for MBP8298 for the treatment of
secondary progressive multiple sclerosis. [click link for full article]

Small Study Investigating Combination Therapy Including ...
Medical News Today (press release) - UK
For four months, participants took 100 milligrams daily of the antibiotic doxycycline in addition to continuing beta interferon therapy. ...
See all stories on this topic

Drug Combo Slows Down Progression of Multiple Sclerosis
Dog Flu Diet and Diseases - Brantford,Ontario,Canada
... doxycycline, which is an acne medication was combined with the MS drug. "We decided to see if it's going to work with patients with multiple sclerosis ...
See all stories on this topic

LSUHSC study brings promising results in treatment of MS
Shreveport Times - Shreveport,LA,USA
The two drugs used are interferon beta-1a, an immune booster already used with multiple sclerosis patients, and doxycycline, a common and safe antibiotic ...
See all stories on this topic

Combining antibiotic with interferon may benefit some MS patients ...
The Canadian Press -
A common antibiotic taken daily by multiple sclerosis patients who are on interferon treatment may be effective in helping some people with the disabling ...
See all stories on this topic

Adding Antibiotics To Medication May Slow MS
Medical News Today - UK
"Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis: An Open-Label Trial." Alireza Minagar; J. Steven Alexander; ...
See all stories on this topic

Antibiotics 'could help slow MS'
BBC News - UK
Adding antibiotics to standard drug therapy may slow down the progress of multiple sclerosis, research suggests. Patients showed fewer symptoms, ...
See all stories on this topic

Biogen Idec backs off plan to sell company MOVERS MARKETPLACE by ...
Therapeutics Daily (subscription) (press release) - Newtown,PA,USA
Biogen Idec, the maker of the multiple sclerosis drug Tysabri, lost more than $6 billion in market value Thursday after it said that it planned to remain ...
See all stories on this topic

BioMS Medical's phase III US multiple sclerosis trial receives ...
CNW Telbec (Communiqués de presse) - Montréal,Québec,Canada
(TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has ...
See all stories on this topic

BioMS Medical's Phase III US Multiple Sclerosis Trial Gets ...
Trading Markets (press release) - Los Angeles,CA,USA
(MS.TO | charts | news | PowerRating) announced that the independent Data Safety Monitoring Board or DSMB has reviewed data from the Company's on-going ...
See all stories on this topic

BioMS Medical's Phase III US Multiple Sclerosis Trial Receives ...
PharmiWeb.com (press release) - Bracknell,England,UK
The primary clinical endp oint for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as ...
See all stories on this topic

MS Society Welcomes Information On Sativex, UK
The MS Society has welcomed an unprecedented move by the Medicines and Healthcare products Regulatory Agency (MHRA) to provide potential prescribers of the unlicensed drug Sativex more information to help them in their decision.
14 Dec 2007

MS Society Supports Call For Improved Information Provision, UK
The MS Society has spoken out in support of a call for better care for people with multiple sclerosis (MS) following new research that suggests people with neurological conditions are left in an information void.
14 Dec 2007

Small Study Investigating Combination Therapy Including Antibiotics For Multiple Sclerosis, UK
A preliminary study suggests that combining beta interferon with an antibiotic may slow the progress of the condition, according to an article posted online December 10 that will appear in the February 2008 print issue of Archives of Neurology, one of the JAMA (Journal of the American Medical Association) /Archives journals.
14 Dec 2007

Genmab Announces Details Of Planned Ofatumumab Phase II Study In Multiple Sclerosis
Genmab A/S (OMX: GEN) announced details of a planned Phase II study of ofatumumab (HuMax-CD20(R)) for the treatment of relapsing remittingmultiple sclerosis (RRMS). Approximately 324 patients will be enrolled in the study which will be conducted under Genmab's collaboration with GlaxoSmithKline (GSK).
14 Dec 2007